Moody’s upgrades Embraer’s rating to ‘Baa2’ from ‘Baa3’; outlook changed to ‘stable’

By Sep 14, 2026

Moody's — Moody's upgrades Embraer's rating to 'Baa2' from 'Baa3'; outlook changed to 'stable' TradingView

Auto-published by the finit.news Events monitor from Moody's; summarized by AI and may contain errors — verify against the primary source. September 14, 2026.

By

Credit Ratings

Kite Realty Group Upgraded by Fitch to BBB+ with Stable Outlook

Sep 14, 2026

Credit Ratings

Private Credit Defaults Climb To 6.3% In August, Fitch Says

Sep 14, 2026

Credit Ratings

Mister Car Wash outlook cut to negative by S&P on dividend debt

Sep 14, 2026

Labor

Oracle begins a new round of layoffs. Read the email.

Regulatory Approvals

Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases

Regulatory Approvals

FDA Approves Topical Photodynamic Therapy for Superficial BCC

Regulatory Approvals

Moody’s upgrades Embraer’s rating to ‘Baa2’ from ‘Baa3’; outlook changed to ‘stable’

By

Financial News For All

Oracle begins a new round of layoffs. Read the email.

Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases

FDA Approves Topical Photodynamic Therapy for Superficial BCC

FDA Approves Aminolevulinic Acid Gel With PDT for Superficial Basal Cell Carcinoma

Moody’s upgrades Embraer’s rating to ‘Baa2’ from ‘Baa3’; outlook changed to ‘stable’

By

Related Post

Kite Realty Group Upgraded by Fitch to BBB+ with Stable Outlook

Private Credit Defaults Climb To 6.3% In August, Fitch Says

Mister Car Wash outlook cut to negative by S&P on dividend debt

Financial News For All

Oracle begins a new round of layoffs. Read the email.

Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases

FDA Approves Topical Photodynamic Therapy for Superficial BCC

FDA Approves Aminolevulinic Acid Gel With PDT for Superficial Basal Cell Carcinoma